[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
December 28, 2005

Risk-Treatment Mismatch for Heart Failure

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2005;294(24):3087-3088. doi:10.1001/jama.294.24.3087-a

To the Editor: In their study of patterns of drug therapy and underlying mortality risk in patients with heart failure, Dr Lee and colleagues1 concluded that patients with congestive heart failure who have the highest risk of mortality have the lowest likelihood of receiving effective drugs, such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs). These paradoxical findings may reflect 2 methodological problems in this study.

First Page Preview View Large
First page PDF preview
First page PDF preview
×